Rafferty Asset Management
AMED

Rafferty Asset Management’s Amedisys AMED Stock Holding History

Rafferty Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,630
Closed -$299K – 971
2020
Q1 		$299K Sell
1,630
-401
-20% -$71.3K 0.01% 438
2019
Q4 		$339K Buy
+2,031
New +$302K 0.01% 768
2019
Q3 		– Sell
-4,253
Closed -$516K – 801
2019
Q2 		$516K Buy
+4,253
New +$505K 0.01% 678
2017
Q3 		– Sell
-13,748
Closed -$864K – 593
2017
Q2 		$864K Buy
+13,748
New +$801K 0.02% 380

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Rafferty Asset Management's AMED Position: Q2 2020 in Review

Rafferty Asset Management sold out of Amedisys (AMED) in Q2 2020, closing a stake of 1,630 shares — an estimated $299K sold.

Rafferty Asset Management first reported a position in AMED in Q2 2017 and held it in 4 quarters. The position peaked at $864K in Q2 2017. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Rafferty Asset Management reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Rafferty Asset Management sold 1,630 Amedisys shares in Q2 2020, an estimated $299K.
  • Rafferty Asset Management first reported a position in Amedisys in Q2 2017 and held it in 4 quarters.
  • Rafferty Asset Management's Amedisys position peaked at $864K in Q2 2017.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Rafferty Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.